HEXO Provides Update on "The Path Forward"; Announces Cost Savings Initiatives
HEXO Corp. has updated its strategic plan, "The Path Forward," aimed at becoming the leading cannabis company in Canada by market share. The company plans to achieve cash flow positivity through cost reductions and organic growth, targeting $175 million in incremental cash flow over fiscal 2022 and 2023. Key initiatives include a 30% reduction in SG&A expenses and optimizing production savings of $30 million. Also, HEXO sold its 25% stake in Belleville Complex for $10.1 million to reduce debt, continuing to lease the facility. Updates will follow as the plan progresses.
- Target of $175 million incremental cash flow over two fiscal years.
- 30% reduction in SG&A expenses expected by FY 2023.
- $30 million in savings identified through production optimization.
- Sale of non-core assets to reduce debt, raising $10.1 million.
- None.
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 11, 2021 to its short form base shelf prospectus dated May 7, 2021 and amended and restated on May 25, 2021.
- On December 14, 2021, HEXO announced “The Path Forward”, a new strategic plan building on the capabilities of its historical business and recent acquisitions to accelerate organic growth, increase market share to become the first amongst its peers to be cash flow positive from operations.
- As part of this strategic plan, the Company expects to reduce its selling, general, and administrative (“SG&A”) expenses by approximately
30% by the end of fiscal 2023. - The Company has identified
$30 million in savings from optimizing its production network and leveraging the capabilities of its recent acquisitions.
GATINEAU, Quebec, Jan. 19, 2022 (GLOBE NEWSWIRE) -- HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) ("HEXO" or the “Company"), a leading producer of high-quality cannabis products, today provided an update on its previously announced strategic plan, "The Path Forward", designed to solidify HEXO’s position as the number one cannabis company in Canada by recreational market share, with the goal of becoming the first amongst its peers to be cash flow positive from operations.
The plan is expected to generate incremental cash flow of approximately
“It is a strategic imperative for HEXO to strengthen its capital position and restructure the Company’s operations to ensure a path to achieving positive cash flow from operations within the next three quarters,” said Scott Cooper, President and CEO of HEXO. “As an organization we are making strategic decisions quickly to ensure we have the optimal operating footprint we need for the next phase in HEXO’s strategic evolution, while remaining focused on the needs of customers and in our continued efforts in product innovation.”
HEXO is committed to providing its shareholders with updates as the Company executes the strategic plan. Today’s announcement provides updates on two of the five strategic pillars: (i) Streamline and Simplify the Organizational Structure, and (ii) Reduce Manufacturing and Production Costs.
Streamline and Simplify the Organizational Structure
To more closely align the Company’s operating costs with its size, HEXO announced significant cost-saving initiatives to reduce SG&A expenses. These initiatives are expected to represent a
Reduce Manufacturing and Production Costs
In addition to the SG&A savings, the Company has also identified approximately
- Transitioning from co-packaging agreement towards in-house production capabilities;
- Leveraging HEXO’s scale to deliver on procurement savings; and
- Reconfiguring the Company’s production network to achieve greater efficiencies, for example, moving vape production and distillate production to the Redecan facility.
Sale of Non-Core Assets and Debt Reduction
Under the strategic plan, the Company has also identified certain non-core assets which may be divested. The Company intends to apply the proceeds from any such sales principally to debt reduction.
As such, HEXO sold its
The sale of the Company’s interest in BCI to Olegna is a “related party transaction” within the meaning of Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions (“MI 61-101”) because Olegna is majority owned and controlled by Mr. Vincent Chiara, a director of HEXO. HEXO is relying on applicable exemptions from the minority approval and valuation requirements of MI 61-101 on the basis that neither the fair market value of the subject matter of, nor the fair market value of the consideration for, the transaction exceeds
The sale price for the Company’s interest in BCI was determined by an arm’s length third party appraisal.
The Company will continue to provide updates on the progress of The Path Forward as they develop.
Forward-Looking Statements
This press release contains forward-looking information and forward-looking statements within the meaning of applicable securities laws ("Forward-Looking Statements"). Forward-Looking Statements are based on certain expectations and assumptions and are subject to known and unknown risks and uncertainties and other factors that could cause actual events, results, performance and achievements to differ materially from those anticipated in these Forward-Looking Statements. Forward-Looking Statements should not be read as guarantees of future performance or results. Readers are cautioned not to place undue reliance on these Forward-Looking Statements, which speak only as of the date of this press release. The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any Forward-Looking Statements as a result of new information or future events, or for any other reason.
This press release should be read in conjunction with the management's discussion and analysis ("MD&A") and unaudited condensed consolidated interim financial statements and notes thereto as at and for the three months ended October 31, 2021. Additional information about HEXO is available on the Company's profile on SEDAR at www.sedar.com and EDGAR at www.sec.gov, including the Company's Annual Information Form for the year ended July 31, 2021 dated October 29, 2021.
About HEXO
HEXO is an award-winning licensed producer of innovative products for the global cannabis market. HEXO serves the Canadian recreational market with a brand portfolio including HEXO, Redecan, UP Cannabis, Namaste Original Stash, 48North, Trail Mix, Bake Sale, REUP and Latitude brands, and the medical market in Canada, Israel and Malta. The Company also serves the Colorado market through its Powered by HEXO® strategy and Truss CBD USA, a joint venture with Molson-Coors. With the completion of HEXO's recent acquisitions of Redecan and 48North, HEXO is a leading cannabis products company in Canada by recreational market share. For more information, please visit hexocorp.com.
For further information, please contact:
Investor Relations:
Media Relations:
(819) 317-0526
FAQ
What is HEXO's strategic plan for 2022?
How much does HEXO plan to reduce its SG&A expenses by FY 2023?
What savings has HEXO identified through its strategic initiatives?